Atlas Trials

Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

Clinical trial NCT05846243 · COMPLETED

Trial details

NCT number
NCT05846243
Sponsor
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SmallpoxMonkeypoxCowpoxVaccinia Virus Infection
Start date
2021-10-01
Primary completion
2021-12-31
Enrollment
334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.